Yakult Honsha (2267) Q4 2026 earnings summary

Executive summary

• Net sales for FY2025 declined 2.7% year-over-year to ¥486,425 million, with operating profit down 18.4% to ¥45,185 million and ordinary profit down 19.5% to ¥61,084 million. Profit attributable to owners of parent fell 2.9% to ¥44,228 million.

• Comprehensive income rose 18.9% to ¥75,106 million, driven by gains in valuation difference on securities and foreign currency translation.

• The company continued to promote its global vision and medium-term management plan, focusing on probiotics and health-related products.

Financial highlights

• Gross profit decreased to ¥286,235 million from ¥295,520 million year-over-year.

• Basic earnings per share was ¥150.72, with net assets per share at ¥2,075.29.

• Equity-to-asset ratio remained stable at 66.4%.

• Cash flow from operating activities dropped to ¥52,121 million from ¥84,687 million, while cash and cash equivalents at year-end were ¥165,042 million.

Outlook and guidance

• FY2026 consolidated net sales are forecast to rise 8.3% to ¥527,000 million, with profit attributable to owners of parent expected to increase 5.1% to ¥46,500 million.

• Operating profit is projected to decrease 2.6% to ¥44,000 million, while ordinary profit is expected to fall 5.9% to ¥57,500 million.

• Annual dividend for FY2026 is planned at ¥72 per share, up ¥2 from the previous year.